A Roanoke man indicted by a federal grand jury on bank robbery charges made his initial court appearance Thursday in federal ...
Truist Financial (TFC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
But Blooper wasn’t just frolicking; he also got to work.
Keith Lerner, Truist Wealth co-CIO, joins 'Squawk on the Street' to discuss the recent equity market stumbles, and more.
Truist initiated coverage of BioNTech (BNTX) with a Buy rating and $172 price target BioNTech is an oncology company “at heart, even though it ...
On Friday, January 10, the US Attorney’s Office of the Western District of Virginia announced a Roanoke man indicted for ...
Regional banks still have room to thrive, says Truist Securities in its note, highlighting three key paths for regional banks ...
Truist upgraded Atlassian (TEAM) to Buy and downgraded Datadog (DDOG) to Hold, while highlighting the outlook for ...
Truist lowered the firm’s price target on Polaris (PII) to $60 from $76 and keeps a Hold rating on the shares as part of a ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Summit Therapeutics (NASDAQ:SMMT), a drug developer challenging pharma giant Merck's (NYSE:MRK) dominance in lung cancer, won ...